Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M8AB
|
||||
Former ID |
DAP000288
|
||||
Drug Name |
Glycine
|
||||
Synonyms |
Aciport; Aminoazijnzuur; Aminoessigsaeure; Amitone; Corilin; Glicina; Glicoamin; Gly; Glycin; Glycinum; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Hgly; Leimzucker; Padil; Polyglycine; Acide aminoacetique; Acido aminoacetico; Acidum aminoaceticum; Aminoacetic acid; Aminoethanoic acid; An alpha amino acid ester; Glycine [INN]; Hampshire glycine; Polyglycine II; Sucre de gelatine; Acide aminoacetique [INN-French]; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum [INN-Latin]; GLY (IUPAC abbrev); GLYCINE, ACS; Glicina [INN-Spanish]; Glycinum [INN-Latin]; Gyn-hydralin; L-Glycine; S04-0135; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; GLYCINE 1.5% IN PLASTIC CONTAINER; Glycine (JP15/USP); Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; H-Gly-OH; H2N-CH2-COOH; L-alpha-amino acids; (1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Dietary supplement
|
||||
Structure |
Download2D MOL |
||||
Formula |
C2H5NO2
|
||||
InChI |
InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)
|
||||
InChIKey |
DHMQDGOQFOQNFH-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 56-40-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
3339, 86929, 585843, 589752, 626974, 827140, 829229, 829387, 830123, 833865, 836630, 836631, 838484, 841093, 3133349, 6435754, 7346033, 7847079, 7887927, 7979426, 8026292, 8026825, 8138085, 8145759, 8150769, 10527483, 11113413, 11528254, 14747327, 16955354, 17404564, 24439112, 24775647, 24849510, 24860042, 24865701, 24873323, 24895210, 24895217, 24895290, 24895306, 24895353, 24895355, 24898980, 24901611, 26718882, 26751653, 33728423, 37415007, 46295148
|
||||
ChEBI ID |
ChEBI:15428
|
||||
SuperDrug ATC ID |
B05CX03
|
||||
SuperDrug CAS ID |
cas=000056406
|
||||
Target and Pathway | |||||
Target(s) | Glutamate [NMDA] receptor subunit epsilon 1 | Target Info | Antagonist | [537546] | |
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Circadian entrainment | |||||
Long-term potentiation | |||||
Glutamatergic synapse | |||||
Dopaminergic synapse | |||||
Alzheimer's disease | |||||
Amyotrophic lateral sclerosis (ALS) | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Nicotine addiction | |||||
Alcoholism | |||||
Systemic lupus erythematosus | |||||
Pathway Interaction Database | Reelin signaling pathway | ||||
References | |||||
Ref 538479 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 016784. | ||||
Ref 542289 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 727). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.